NPS-1034 is primarily investigated for its potential therapeutic applications, particularly in the field of oncology. Research suggests that it may act as a kinase inhibitor, targeting specific pathways involved in cancer cell proliferation and survival. Its application is being explored in preclinical studies to evaluate its efficacy in inhibiting tumor growth and metastasis, especially in cancers resistant to conventional treatments. Additionally, NPS-1034 is studied for its potential to enhance the effects of existing chemotherapy drugs, offering a synergistic approach to cancer therapy. Its role in modulating signaling pathways also makes it a candidate for treating other diseases involving abnormal cell signaling, such as certain inflammatory or autoimmune conditions. Further research is ongoing to determine its safety, pharmacokinetics, and clinical viability.